LAHORE (PR) - ICI Pakistan and AstraZeneca have maintained a successful partnership in Pakistan for the past 34 years. ICIs sustainable business applications, ethical practices, highly skilled team and wide geographical footprint have established astraZeneca as the number one company in the Cardiology segment and as a leader in the Oncology segment. In order to strengthen the partnership and pursue an aggressive growth plans, the AstraZeneca office in Pakistan will now support ICI in launching newer, more innovative AstraZeneca brands, and widen the scope of its medical research activities by conducting clinical trials.